Biotech Values

[DewDiligence]

Details of SHPG-BXLT merger:

http://finance.yahoo.com/news/shire-combine-baxalta-creating-global-123000568.html

…Baxalta shareholders will receive $18.00 in cash and 0.1482 Shire ADS per Baxalta share. Based on Shire's closing ADS price on January 8, 2016, this implies a total current value of $45.57 per Baxalta share, representing an aggregate consideration of approximately $32 billion.

…The value of the offer as of Shire's January 8, 2016 closing ADS price represents a premium of approximately 37.5% to Baxalta's unaffected share price on August 3, 2015, the day prior to the public announcement of Shire's initial offer for Baxalta. This will provide Baxalta shareholders with approximately 34% ownership in the combined company.

Closing of the transaction is subject to approval by Baxalta and Shire shareholders… The parties expect the transaction to close mid-2016.

CC slides:
http://rarediseaseleader.com/wp-content/uploads/2016/01/Shire-to-combine-with-Baxalta-Second-Announcement.pdf